Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer

Wook Kim(The Catholic University of Korea Yeouido St. Mary's Hospital), Hyung‐Ho Kim(Seoul National University Bundang Hospital), Sang‐Uk Han(Ajou University), Min-Chan Kim(Dong-A University), Woo Jin Hyung(Yonsei University), Seung Wan Ryu(Keimyung University), Gyu Seok Cho(Catholic University of Korea), Chan Young Kim(Jeonbuk National University Hospital), Han‐Kwang Yang(Seoul National University), Do Joong Park(Seoul National University Bundang Hospital), Kyo Young Song(Dong-A University), Sang Il Lee(Chungnam National University Hospital), Seung Yub Ryu(Chonnam National University), Joo-Ho Lee(The Catholic University of Korea Yeouido St. Mary's Hospital), Hyuk‐Joon Lee(Seoul National University)
Annals of Surgery
September 10, 2015
Cited by 626

Abstract

OBJECTIVE: To determine the safety of laparoscopy-assisted distal gastrectomy (LADG) compared with open distal gastrectomy (ODG) in patients with clinical stage I gastric cancer in Korea. BACKGROUND: There is still a lack of large-scale, multicenter randomized trials regarding the safety of LADG. METHODS: A large-scale, phase 3, multicenter, prospective randomized controlled trial was conducted. The primary end point was 5-year overall survival. Morbidity within 30 postoperative days and surgical mortality were compared to evaluate the safety of LADG as a secondary end point RESULTS: : A total of 1416 patients were randomly assigned to the LADG group (n = 705) or the ODG group (n = 711) between February 1, 2006, and August 31, 2010, and 1384 patients were analyzed for modified intention-to-treat analysis (ITT) and 1256 were eligible for per protocol (PP) analysis (644 and 612, respectively). In the PP analysis, 6 patients (0.9%) needed open conversion in the LADG group. The overall complication rate was significantly lower in the LADG group (LADG vs ODG; 13.0% vs 19.9%, P = 0.001). In detail, the wound complication rate of the LADG group was significantly lower than that of the ODG group (3.1% vs 7.7%, P < 0.001). The major intra-abdominal complication (7.6% vs 10.3%, P = 0.095) and mortality rates (0.6% vs 0.3%, P = 0.687) were similar between the 2 groups. Modified ITT analysis showed similar results with PP analysis. CONCLUSIONS: LADG for patients with clinical stage I gastric cancer is safe and has a benefit of lower occurrence of wound complication compared with conventional ODG.


Related Papers

No related papers found

Powered by citation graph analysis